2,855
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B

, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 756-778 | Received 11 Jul 2019, Accepted 29 Oct 2019, Published online: 12 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mohube Betty Maepa, Kristie Bloom, Abdullah Ely & Patrick Arbuthnot. (2021) Hepatitis B virus: promising drug targets and therapeutic implications. Expert Opinion on Therapeutic Targets 25:6, pages 451-466.
Read now
Rajan George, Allan Ma, Bruce Motyka, Yuenian Eric Shi, Qiang Liu & Philip Griebel. (2020) A dendritic cell-targeted chimeric hepatitis B virus immunotherapeutic vaccine induces both cellular and humoral immune responses in vivo. Human Vaccines & Immunotherapeutics 16:4, pages 779-792.
Read now

Articles from other publishers (7)

Maria Lteif, Marc Pallardy & Isabelle Turbica. (2023) Antibodies internalization mechanisms by dendritic cells and their role in therapeutic antibody immunogenicity. European Journal of Immunology.
Crossref
Xuejie Wu & Feng Xu. (2023) Dendritic cell‐based immunotherapy: A potential therapeutic option for chronic Hepatitis B virus infection. Clinical and Translational Discovery 3:1.
Crossref
Jia-Rui Zheng, Zi-Long Wang & Bo Feng. (2022) Hepatitis B functional cure and immune response. Frontiers in Immunology 13.
Crossref
Yi‐Jun Jia, Jun‐Yao Xia, Fu‐Yi Jiang, Yang Li, Guo Chen & Bin Zhu. (2022) Antigenic epitope screening and functional modification of mannose enhance the efficacy of largemouth bass virus subunit vaccines. Journal of Fish Diseases 45:11, pages 1635-1643.
Crossref
Minghui Li, Yuanjiao Gao, Liu Yang, Yanjie Lin, Wen Deng, Tingting Jiang, Xiaoyue Bi, Yao Lu, Lu Zhang, Ge Shen, Ruyu Liu, Shuling Wu, Min Chang, Mengjiao Xu, Leiping Hu, Rui Song, Yuyong Jiang, Wei Yi & Yao Xie. (2022) Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B. Frontiers in Immunology 13.
Crossref
Jinglan Jin, Yuwei Liu, Xiaotong Xu, Zhongfeng Wang & Junqi Niu. (2021) The association between Fc gamma RIIb expression levels and chronic hepatitis B virus infection progression. BMC Infectious Diseases 21:1.
Crossref
Efthymios P Tsounis, Evanthia Tourkochristou, Athanasia Mouzaki & Christos Triantos. (2021) Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure. World Journal of Gastroenterology 27:21, pages 2727-2757.
Crossref